In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Tomasz TodrykDepartment of Pharmaceutical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.
Monika BudnickaDepartment of Pharmaceutical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0003-0088-8858 Lukasz PajchelDepartment of Pharmaceutical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0003-1985-0876 Hanna KierońskaPikralida Sp. z.o.o, Uniwersytetu Poznańskiego 10 Street, 61-614 Poznan, Poland.
Maciej DawidowskiDepartment of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland.ORCID 0000-0002-7262-5718 Krzysztof Adam StępieńDepartment of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0003-4621-1551 Joanna GiebułtowiczDepartment of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0002-2567-4453 Sebastian GranicaDepartment of Pharmaceutical Biology, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0002-1876-1321 Joanna KolmasDepartment of Pharmaceutical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0002-4417-5836 Jakub P PiwowarskiMicrobiota Lab, Department of Pharmaceutical Microbiology and Bioanalysis, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.ORCID 0000-0002-5011-0983 Funding
Medical Research Agency of Poland 2024/ABM/03/KPO/KPOD.07.07-IW.07-0135/24-00
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anti-inflammatory effectatopic dermatitisflavanolgut microbiota-derived metabolitespreformulationtopical formulation
Identifiers
PMID42357365
PMCPMC13307394
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390